A new Hydrogel-Based Platform to preserve live patient-derived tumour tissues in the lab could pave the way for faster, more ...

A Yale team of researchers led by noted Indian American oncologist Dr. Kiran Turaga has developed new national guidelines for ...

A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more ...

Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer ...

This offers hope to some patients who face an average survival rate of just several months. Read more at straitstimes.com.

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 can improve survival in patients with gastric cancer and peritoneal metastasis, according to research presented at the ASCO ...

Findings A total of 4072 patients were included, of whom 1835 (45.1%) had peritoneal metastases. Of these, 58.1% had isolated peritoneal metastases. For patients with metastatic gastric cancer treated ...

Patients with gastric cancer peritoneal metastases (GCPM) often face an exceptionally grim prognosis, with severe symptoms and rapid disease progression. Median survival rates range from just three to ...

SINGAPORE: A recent breakthrough in gastric cancer research offers new hope to patients suffering from peritoneal metastasis, a condition associated with advanced stages of the disease.

Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases. Gastroenterology, 2024; DOI: 10.1053/j.gastro.2024.08.007 ...